Literature DB >> 32277444

Exosomal miRNAs in osteoarthritis.

Aynaz Mihanfar1,2, Seyed Kazem Shakouri3, Mohammad Hassan Khadem-Ansari1, Amir Fattahi4, Zeinab Latifi5,3, Hamid Reza Nejabati6,7,8,9, Mohammad Nouri10,11,12.   

Abstract

Exosomes, as lipid nanostructure, are secreted by approximately all cell types within the body and actively involved in either short or long distances cell-cell communication in an autocrine and paracrine manner. Recently, exosomes are widely used as a nanocarrier for delivery of various nucleotide- or protein passed molecules including miRNA, and drugs into various cells, as a therapeutic strategy in a broad range of diseases including osteoarthritis. Osteoarthritis is one of the most common debilitating chronic musculoskeletal disorders with a multifaceted condition and an increasing impact on the quality of life. Therefore, this review aims to focus on the current knowledge of the exosomal miRNAs in the osteoarthritis to address their potential therapeutic application.

Entities:  

Keywords:  Exosomes; Musculoskeletal disorder; Osteoarthritis; miRNA

Mesh:

Substances:

Year:  2020        PMID: 32277444     DOI: 10.1007/s11033-020-05443-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  96 in total

Review 1.  Research progress on osteoarthritis treatment mechanisms.

Authors:  Yun-Tao Gu; Jian Chen; Zhu-Long Meng; Wan-Yu Ge; Yang-Yang Bian; Shao-Wen Cheng; Chen-Kun Xing; Jiang-Ling Yao; Jian Fu; Lei Peng
Journal:  Biomed Pharmacother       Date:  2017-07-20       Impact factor: 6.529

Review 2.  Osteoarthritis pathogenesis: a review of molecular mechanisms.

Authors:  Bingjiang Xia; Jushi Zhang; Songfeng Hu; Hongting Jin; Peijian Tong
Journal:  Calcif Tissue Int       Date:  2014-10-14       Impact factor: 4.333

Review 3.  Extracellular vesicles: A new therapeutic strategy for joint conditions.

Authors:  Miguel Tofiño-Vian; Maria Isabel Guillén; Maria José Alcaraz
Journal:  Biochem Pharmacol       Date:  2018-02-07       Impact factor: 5.858

Review 4.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.

Authors:  Mohit Kapoor; Johanne Martel-Pelletier; Daniel Lajeunesse; Jean-Pierre Pelletier; Hassan Fahmi
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

Review 5.  Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes.

Authors:  Rana Jahanban-Esfahlan; Saeed Mehrzadi; Russel J Reiter; Khaled Seidi; Maryam Majidinia; Hossein Bannazadeh Baghi; Nasrin Khatami; Bahman Yousefi; Alireza Sadeghpour
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

6.  The John N. Insall Award: Do Intraarticular Injections Increase the Risk of Infection After TKA?

Authors:  Nicholas A Bedard; Andrew J Pugely; Jacob M Elkins; Kyle R Duchman; Robert W Westermann; Steve S Liu; Yubo Gao; John J Callaghan
Journal:  Clin Orthop Relat Res       Date:  2017-01       Impact factor: 4.176

Review 7.  Intra-articular treatment options for knee osteoarthritis.

Authors:  Ian A Jones; Ryan Togashi; Melissa L Wilson; Nathanael Heckmann; C Thomas Vangsness
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

Review 8.  Osteoblast role in osteoarthritis pathogenesis.

Authors:  Nicola Maruotti; Addolorata Corrado; Francesco P Cantatore
Journal:  J Cell Physiol       Date:  2017-05-24       Impact factor: 6.384

Review 9.  Osteoarthritis pathogenesis - a complex process that involves the entire joint.

Authors:  G S Man; G Mologhianu
Journal:  J Med Life       Date:  2014-03-25

Review 10.  Exosomes: mediators of bone diseases, protection, and therapeutics potential.

Authors:  Jyotirmaya Behera; Neetu Tyagi
Journal:  Oncoscience       Date:  2018-06-23
View more
  5 in total

1.  SEMA6D, Negatively Regulated by miR-7, Contributes to C28/I2 chondrocyte's Catabolic and Anabolic Activities via p38 Signaling Pathway.

Authors:  Haoyu Yang; Zhicheng Yang; Zhentang Yu; Chenwei Xiong; Yi Zhang; Junjie Zhang; Yong Huang; Xindie Zhou; Jin Li; Nanwei Xu
Journal:  Oxid Med Cell Longev       Date:  2022-06-16       Impact factor: 7.310

2.  miR-125a-5p-abundant exosomes derived from mesenchymal stem cells suppress chondrocyte degeneration via targeting E2F2 in traumatic osteoarthritis.

Authors:  Qingqing Xia; Quan Wang; Feng Lin; Junjuan Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  DNA methylation and noncoding RNA in OA: Recent findings and methodological advances.

Authors:  Vladislav Izda; Jake Martin; Cassandra Sturdy; Matlock A Jeffries
Journal:  Osteoarthr Cartil Open       Date:  2021-08-14

Review 4.  Exosomes: Small Vesicles with Important Roles in the Development, Metastasis and Treatment of Breast Cancer.

Authors:  Ling'ao Meng; Kedong Song; Shenglong Li; Yue Kang
Journal:  Membranes (Basel)       Date:  2022-08-12

5.  Extracellular Vesicle-Mediated miR-150-3p Delivery in Joint Homeostasis: A Potential Treatment for Osteoarthritis?

Authors:  Huan Wang; Jun Shu; Chengfei Zhang; Yang Wang; Rongxing Shi; Fan Yang; Xuezhang Tang
Journal:  Cells       Date:  2022-09-05       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.